PCSK9 post-transcriptional regulation: Role of a 3′UTR microRNA-binding site variant in linkage disequilibrium with c.1420G
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 314, 63-70
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Pfizer
This publication has 40 references indexed in Scilit:
- Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populationsLipids in Health and Disease, 2013
- Mutation in the PCSK9 Gene in Omani Arab Subjects with Autosomal Dominant Hypercholesterolemia and its Effect on PCSK9 Protein StructureOman Medical Journal, 2013
- Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE allelesAtherosclerosis, 2010
- The Vienna RNA WebsuiteNucleic Acids Research, 2008
- The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. menClinical Science, 2007
- A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein CholesterolThe American Journal of Human Genetics, 2006
- Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9Nature Genetics, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Genetic variants in PCSK9 affect the cholesterol level in JapaneseJournal of Human Genetics, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003